IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 217 filers reported holding IMMUNOMEDICS INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $6,254,000 | +30.7% | 73,546 | -45.5% | 0.01% | +37.5% |
Q2 2020 | $4,785,000 | +1295.0% | 135,027 | +430.3% | 0.01% | +700.0% |
Q1 2020 | $343,000 | -5.2% | 25,460 | +35.3% | 0.00% | – |
Q1 2019 | $362,000 | -59.0% | 18,819 | -69.6% | 0.00% | -100.0% |
Q4 2018 | $884,000 | -48.8% | 61,953 | -25.2% | 0.00% | -50.0% |
Q3 2018 | $1,725,000 | -14.9% | 82,795 | -3.3% | 0.00% | 0.0% |
Q2 2018 | $2,026,000 | +51.2% | 85,595 | -6.6% | 0.00% | +100.0% |
Q1 2018 | $1,340,000 | -19.8% | 91,685 | -11.3% | 0.00% | -50.0% |
Q4 2017 | $1,670,000 | +25.4% | 103,332 | +8.5% | 0.00% | 0.0% |
Q3 2017 | $1,332,000 | +90.8% | 95,265 | +20.6% | 0.00% | +100.0% |
Q2 2017 | $698,000 | +69.4% | 79,015 | +24.2% | 0.00% | 0.0% |
Q1 2017 | $412,000 | +421.5% | 63,626 | +285.6% | 0.00% | – |
Q4 2014 | $79,000 | -55.4% | 16,500 | -65.4% | 0.00% | – |
Q3 2014 | $177,000 | -42.3% | 47,700 | -43.3% | 0.00% | -100.0% |
Q2 2014 | $307,000 | -12.0% | 84,200 | +1.4% | 0.00% | 0.0% |
Q1 2014 | $349,000 | +34.7% | 83,000 | +47.2% | 0.00% | 0.0% |
Q4 2013 | $259,000 | -25.8% | 56,400 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $349,000 | +106.5% | 56,400 | +81.9% | 0.00% | 0.0% |
Q2 2013 | $169,000 | +85.7% | 31,000 | 0.0% | 0.00% | – |
Q4 2012 | $91,000 | – | 31,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |